The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPM.L Regulatory News (MPM)

  • There is currently no data for MPM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sch 1 - RII plc

27 Jan 2005 07:00

AIM27 January 2005 ANNOUNCEMENT TO BE MADE BY AIM APPLICANT AT LEAST 10 BUSINESS DAYS PRIOR TO ADMISSION ALL APPLICANTS MUST COMPLETE THE FOLLOWING: COMPANY NAME:RII plc (to be renamed Mister Pharmaceuticals) COMPANY ADDRESS:56 Queen Anne Street, London COMPANY POSTCODE:W1G 8LA COUNTRY OF INCORPORATION:England COMPANY BUSINESS:Biotechnology DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares, nominal value and issue price):1,553,698 in Ordinary Shares of 0.1p each CAPITAL TO BE RAISED ON ADMISSION:£3,000,000 FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS:Robert Stubbs - ChairmanClive McGuire - Non Executive DirectorDr Paul Sharpe - Proposed Chairman and Chief Executive OfficerRobert Aubrey - Proposed Chief Operating OfficerDr Peter Blower - Proposed Executive Director PERSON(S) INTERESTED IN 3% OR MORE OF THE ISSUER'S CAPITAL, EXPRESSED AS APERCENTAGE OF THE ISSUED SHARE CAPITAL STATING WHETHER BEFORE OR AFTERADMISSION: Before admission the following people are directly interested in 3% or more of the issued shares in the Company; % of Issued ShareShareholder No. of Shares Capital Pershing Keen Nominees Limited HHCLT Acct 28,572,231 17.7P Bullen a/c M EdwardsPershing Keen Nominees Limited PSL981 Acct 11,675,673 7.2Langham Investment Corporation Limited 10,000,000 6.2B SalmanpourRock (Nominees) Limited 1802730 Account 8,695,652 5.4Clive RobertsW B Nominees Limited 5,872,101 3.6Maurice Gould 5,797,101 3.6Philip John Rowen 5,797,101 3.6Ian Weaver 5,797,101 3.6Shuman Brothers Inc 4,881,754 3.0 NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (G) OF THE AIM RULES.N/A ANTICIPATED ACCOUNTING REFERENCE DATE:31 March EXPECTED ADMISSION DATE:Friday 25 February 2005 NAME AND ADDRESS OF NOMINATED ADVISERInsinger de Beaufort44 Worship StreetLondonEC2A 2JT NAME AND ADDRESS OF BROKERInsinger de Beaufort44 Worship StreetLondonEC2A 2JT DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BEAVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THEAPPLICANT AND THE ADMISSION OF ITS SECURITIES56 Queen Anne Street, London W1G 8LA DATE OF NOTIFICATION/ STATEMENT27 January 2005 NEW/ UPDATE (see note): NEW LISTED APPLICANTS MUST ALSO COMPLETE THE FOLLOWING: DETAILS OF THE APPLICANT'S STRATEGY FOLLOWING ADMISSION INCLUDING, IN THE CASEOF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGYN/A A DESCRIPTION OF ANY SIGNIFICANT CHANGE IN FINANCIAL OR TRADING POSITION OF THEAPPLICANT, WHICH HAS OCCURRED SINCE THE END OF THE LAST FINANCIAL PERIOD FORWHICH AUDITED STATEMENTS HAVE BEEN PUBLISHED OR AN APPROPRIATE NEGATIVESTATEMENTN/A A STATEMENT THAT THE DIRECTORS OF THE APPLICANT HAVE NO REASON TO BELIEVE THATITS WORKING CAPITAL WILL BE INSUFFICIENT FOR AT LEAST TWELVE MONTHS FROM THEDATE OF ITS ADMISSIONN/A DETAILS OF ANY LOCK-IN ARRANGEMENTS PURSUANT TO RULE 7 OF THE AIM RULES.N/A This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Jun 20087:00 amRNSAHS Meeting
25th Jun 200810:28 amRNSDirector/PDMR Shareholding
24th Jun 200810:23 amRNSResult of Annual General Meet
24th Jun 20087:00 amRNSAGM Statement
16th Jun 20087:30 amRNSTEMPUS study fully enrolled
4th Jun 20087:00 amRNSAnnual Report and Accounts
2nd Jun 20087:00 amRNSUS Marketing Consultant
22nd May 20087:00 amRNSPreliminary Results
12th Mar 20087:00 amRNSAura trial fully enrolled
5th Feb 20087:00 amRNSTEMPUS Trial Update
3rd Dec 20077:00 amRNSInterim Results
16th Oct 20077:00 amRNSTEMPUS trial starts in US
4th Oct 200711:06 amRNSChange of Registered Office
28th Sep 200711:32 amRNSDirector/PDMR Shareholding
17th Aug 20077:00 amRNSAIM Rule 26
16th Jul 200711:29 amRNSResult of AGM
16th Jul 20077:00 amRNSAGM Statement
2nd Jul 20074:13 pmRNSHolding(s) in Company
27th Jun 20077:01 amRNSIHS Scientific Meeting
21st Jun 20075:05 pmRNSAnnual Report and Accounts
13th Jun 20077:02 amRNSPreliminary Results
7th Jun 20077:02 amRNSAHS Scientific Meeting
1st Jun 20078:30 amRNSTotal Voting Rights
18th May 20079:20 amRNSAdditional Listing
30th Apr 20076:22 pmRNSHolding(s) in Company
30th Apr 200712:16 pmRNSTotal Voting Rights
11th Apr 20074:39 pmRNSConversion of Loan Note
2nd Apr 20073:27 pmRNSHolding(s) in Company
2nd Apr 20072:55 pmRNSHolding(s) in Company
2nd Apr 20071:26 pmRNSDirector/PDMR Shareholding
30th Mar 20079:32 amRNSTotal Voting Rights
27th Mar 20077:01 amRNSBoard Appointments
26th Mar 200710:31 amRNSResult of EGM
2nd Mar 20077:30 amRNSGPB17m fundraising
9th Jan 20077:01 amRNSPositive Tonabersat Study
20th Dec 20065:43 pmRNSTotal Voting Rights
1st Dec 20067:01 amRNSInterim Results
17th Nov 20067:01 amRNSPlacing
25th Oct 200610:20 amRNSResult of AGM
25th Oct 20067:01 amRNSAGM Statement
27th Sep 20067:00 amRNSNIH Collaboration
20th Sep 20067:02 amRNSPreliminary Results
7th Sep 20067:00 amRNSAdditional Indications
15th Aug 200611:37 amRNSNotification of Interests
20th Jun 20067:00 amRNSStart of Phase II Trial
24th May 20067:01 amRNSUCLA Collaboration
21st Mar 20067:00 amRNSStart of Phase II Trial
8th Mar 20067:03 amRNSChange of Adviser
13th Jan 20067:00 amPRNRe Agreement
8th Dec 20057:00 amPRNInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.